✦ LIBER ✦

Trastuzumab adds benefit to chemo in HER2+ breast cancer

Book ID: 120847988
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715770-00048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HER2 Status and Benefit from Adjuvant Tr

HER2 Status and Benefit from Adjuvant Trastuzumab in Breast Cancer

✍ Paik, Soonmyung; Kim, Chungyeul; Wolmark, Norman 📂 Article 📅 2008 🏛 Massachusetts Medical Society 🌐 English ⚖ 164 KB

Trastuzumab tallies up in HER2+ breast c

Trastuzumab tallies up in HER2+ breast cancer

✍ Pene, S 📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 184 KB

Tanespimycin + trastuzumab promising in

Tanespimycin + trastuzumab promising in HER 2+ breast cancer

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

HER2-Positive Breast Cancer: From Trastu

HER2-Positive Breast Cancer: From Trastuzumab to Innovatory Anti-HER2 Strategies

✍ Nicolas Whenham; Véronique D'Hondt; Martine J. Piccart 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 352 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 125 KB